newsfilter
← Latest News
Business Wire·

OS Therapies Announces Closing of $6 Million Private Placement

Funding expected to provide cash runway into 2026 98% of investment in private placement from Pre-IPO and/or IPO investors Data update from OST-HER2 Phase 2b clinical trial in recurrent, resected metastatic